SCHEMBL4937635

SCHEMBL4937635

O=S(=O)(c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O)N1CCNC(CBr)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.41
MAPT P10636 6/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 3/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
PKLR P30613 1/20 0.32
USP2 O75604 1/20 0.32
ALOX15 P16050 1/20 0.32
ACLY P53396 1/20 0.32
GFER P55789 1/20 0.32
TDO2 P48775 1/20 0.31
GAA P10253 1/20 0.30
PKM P14618 1/20 0.30
MAPK1 P28482 1/20 0.30
HTT P42858 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940502 0.81 HSP90AA1 (0.47) HSP90AA1MAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL4941311 0.79 HSP90AA1 (0.48) HSP90AA1MAPTALDH1A1LMNAKMT2A
SCHEMBL4936289 0.71 HSP90AA1 (0.48) HSP90AA1ALDH1A1LMNAKMT2AACLY
SCHEMBL4939580 0.71 HSP90AA1 (0.58) HSP90AA1MAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL4940684 0.71 HSP90AA1 (0.53) HSP90AA1MAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL4933407 0.70 HSP90AA1 (0.55) HSP90AA1MAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL4943270 0.70 HSP90AA1 (0.45) HSP90AA1MAPTALDH1A1KDM4EKMT2A
SCHEMBL4939553 0.70 HSP90AA1 (0.70) HSP90AA1MAPTSMN1; SMN2ALDH1A1GAA
SCHEMBL4937766 0.69 HSP90AA1 (0.48) HSP90AA1ALDH1A1LMNA
SCHEMBL4939987 0.69 HSP90AA1 (0.45) HSP90AA1MAPTSMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP claimed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US claimed
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP disclosed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182857-A1 Triazole Derivatives HSP90AB1, HSP90AA1, HSP90B1 HSP90AA1 2/4885MAPT 2318/4885SMN1; SMN2 4072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.